Exact Mass: 605.1332046

Exact Mass Matches: 605.1332046

Found 20 metabolites which its exact mass value is equals to given mass value 605.1332046, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Pelargonidin 3-O-3,6-O-dimalonylglucoside

C27H25O16 (605.114255)

Gadobutrol

4,7,10-tris(carboxymethyl)-1-[(2S,3R)-1,3,4-trihydroxybutan-2-yl]-1,4,7,10-tetraaza-13-gadolinatetracyclo[5.5.1.0^{4,13}.0^{10,13}]tridecane-1,4,7,10-tetraium-13-uide

C18H31GdN4O9 (605.1332046)

Gadobutrol is only found in individuals that have used or taken this drug.It is a contrast agent used in magnetic resonance imaging (MRI). V - Various > V08 - Contrast media > V08C - Magnetic resonance imaging contrast media > V08CA - Paramagnetic contrast media

PYRIMIDINE DERIVATIVE

3-({4-amino-5-[(4-chlorophenyl)methyl]pyrimidin-2-yl}imino)-5-chloro-1-{[4-(3-chlorophenyl)piperazin-1-yl]methyl}-2,3-dihydro-1H-indol-2-one

C30H26Cl3N7O (605.1264316)

Tezosentan

N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-[2-(2H-1,2,3,4-tetrazol-5-yl)pyridin-4-yl]pyrimidin-4-yl]-5-(propan-2-yl)pyridine-2-sulfonamide

C27H27N9O6S (605.1804922000001)

D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents C28313 - Endothelin Receptor Antagonist

Gadobutrol

gadolinium(3+) ion 2-[4,7-bis(carboxylatomethyl)-10-(1,3,4-trihydroxybutan-2-yl)-1,4,7,10-tetraazacyclododecan-1-yl]acetate

C18H31GdN4O9 (605.1332046)

V - Various > V08 - Contrast media > V08C - Magnetic resonance imaging contrast media > V08CA - Paramagnetic contrast media

Naphthoquine Phosphate

C24H34ClN3O9P2 (605.1458724000001)

N-[4-amino-3-(5,10-dihydro-5,10-dioxoanthra[2,3-d]thiazol-2-yl)-9,10-dihydro-9,10-dioxo-1-anthryl]benzamide

C36H19N3O5S (605.1045364)

Prochlorperazine maleate

Prochlorperazine dimaleate

C28H32ClN3O8S (605.1598542)

D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent > C740 - Phenothiazine D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D005765 - Gastrointestinal Agents > D000932 - Antiemetics

chloro(di-2-norbornylphosphino)(2-dimethylaminomethylferrocen-1-yl)palladium(ii)

C27H39ClFeNPPd (605.0892634)

C30H27N3O9S

C30H27N3O9S (605.1467932)

Gadovist

C18H31GdN4O9 (605.1332046)

V - Various > V08 - Contrast media > V08C - Magnetic resonance imaging contrast media > V08CA - Paramagnetic contrast media

[(2R,3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl] [hydroxy-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphoryl] hydrogen phosphate

C18H29N3O16P2 (605.1023014000001)

(3E)-3-[4-amino-5-[(4-chlorophenyl)methyl]pyrimidin-2-yl]imino-5-chloro-1-[[4-(3-chlorophenyl)piperazin-1-yl]methyl]indol-2-one

C30H26Cl3N7O (605.1264316)

Prochlorperazine bimaleate

C28H32ClN3O8S (605.1598542)

D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D005765 - Gastrointestinal Agents > D000932 - Antiemetics

Gadavist

Gadobutrol

C18H31GdN4O9 (605.1332046)

V - Various > V08 - Contrast media > V08C - Magnetic resonance imaging contrast media > V08CA - Paramagnetic contrast media

Sirtuin modulator 1

C31H32ClN5O2S2 (605.1685842)

Sirtuin modulator 1 is a modulator of SIRTl, a homolog of SIRT3, with EC1.5 of < 1 μM, extracted from patent WO 2010071853 A1, Compound No.4.

Pelargonidin 3-O-3',6'-O-dimalonylglucoside

C27H25O16 (605.114255)